Genomic & Biopharma News

Israel-based DiA Imaging inks deal with GE Healthcare on ultrasound devices
DiA Imaging Analysis, a medical imaging software company based in Israel, has inked a deal with GE Healthcare to develop automated imaging analysis technology.
Fierce Biotech, 2017-11-20 14:37:18

Simple mirror technique boosts the performance of diSPIM, study says
Researchers from the Marine Biological Laboratory (MBL) have significantly improved the efficiency, resolution, and speed of a light-sheet microscope, by using a simple mirror technique and not-so-easy computational analysis, with a wide range of applications for better imaging of embryos and live cells.
News Medical Life Sciences, 2017-11-20 14:29:00

Harnessing the microbiome potential
Spring is underway in parts of the US, and while Florida by no means undergoes the dramatic reappearance of foliage or colorful clumps of daffodils and azaleas, the southern part of the sunshine state experiences its share of spring renewals.  For instance, recently a brood of Muscovy duck (Cairina moschata) hatchlings appeared near Ocean Ridge Biosciences' laboratory.
ORB Company Blog, 2017-03-31 21:41:45

Cancer drugs may offer new way to control high blood pressure
Drugs designed to halt cancer growth may offer a new way to control high blood pressure (hypertension), say Georgetown University Medical Center investigators.
News Medical Life Sciences, 2017-11-20 14:22:45

An undervalued indication for Regeneron's Eylea could help it weather Novartis threat: Analyst
With a rival Novartis drug heading to market, Regeneron recently disclosed that a bigger-than-expected portion of its Eylea revenue might be in jeopardy. But the eye drug might have a shot at a new indication that could save the day.
Fierce Pharma, 2017-11-20 14:17:43

DBV climbs as peanut allergy safety data come in clean
DBV Technologies has posted phase 3 data suggesting safety and compliance are unlikely to scuttle its hopes of winning approval of peanut allergy treatment Viaskin Peanut. Shares in DBV rose on the back of the data, going a little way toward erasing the big drop it suffered after missing its primary efficacy endpoint.
Fierce Biotech, 2017-11-20 14:15:16

Acorda dumps $363M Parkinson’s drug after patient deaths
Acorda Therapeutics is scrapping its Parkinson’s disease drug tozadenant following patient deaths in its phase 3 trial. The action marks the end for an oral adenosine A2a receptor antagonist Acorda paid $363 million in cash for last year.
Fierce Biotech, 2017-11-20 13:36:08

Harnessing the microbiome potential
Spring is underway in parts of the US, and while Florida by no means undergoes the dramatic reappearance of foliage or colorful clumps of daffodils and azaleas, the southern part of the sunshine state experiences its share of spring renewals.  For instance, recently a brood of Muscovy duck (Cairina moschata) hatchlings appeared near Ocean Ridge Biosciences' laboratory.
ORB Company Blog, 2017-03-31 21:41:45

Long non-coding RNAs involved in resistance to fungal disease
Long non-coding RNAs (lncRNAs) have several known functions in plant development, but their possible roles in responding to plant disease remain largely unresolved. In this study, researchers at Durham University and Huazhong Agricultural University described a comprehensive disease-responding lncRNA profiles in defense against a cotton fungal disease Verticillium dahliae. The researchers further revealed the conserved ...
lncRNA Research and Industry News, 2017-11-20 13:34:59

Biotech vet Julian Adams takes top job at Gamida Cell
Novartis-backed biotech Gamida Cell has named Julian Adams, Ph.D.—its current chair and chief scientific officer of Clal Biotech—as its new CEO.
Fierce Biotech, 2017-11-20 13:33:57

After penning Loxo deal, Bayer signs up to another billion-dollar R&D pact
Bayer has signed a new and potentially major research pact with Japan’s PeptiDream, marking it the second big biobucks deal of its kind for the German pharma in the past week.
Fierce Biotech, 2017-11-20 13:31:37